• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Average American Customer Satisfaction Index (ACSI) evaluation score from surveys completed on the mobile site during the month

Dictionary: The American Customer Satisfaction Index (ACSI) is a comprehensive reflection of the citizen experience with federal government websites, and it serves as a critical checkpoint for evaluating the success and performance of the federal government’s online initiatives. Visitors to federal government websites are randomly presented with online satisfaction surveys when navigating through the sites and the survey assigns an overall customer satisfaction score based on several individual elements that comprise satisfaction, like content, search, navigation, and site performance. For 2013, FDA received over 9800 completed surveys. This demonstrates that citizens are willing to share their voices to help FDA improve. The use of the ACSI methodology and technology then enables agency leaders to determine which website improvements will have the greatest impact on future usage and recommendations. An ACSI score of 72 is the average score for federal agencies.

Information is current as of September 30, 2018

Fiscal Year - 2018

Skip graphic and jump to text data

Oct 2017N/A76
Nov 2017N/A74
Dec 2017N/A75
Jan 2018N/A76
Feb 2018N/A76
Mar 2018N/A76
Apr 2018N/A73
May 2018N/A74
Jun 2018N/A74
Jul 2018N/AN/A
Aug 2018N/AN/A
Sep 2018N/AN/A

FY 2018 Total: 74


  • OEA is transitioning to a new system as of July 2018. New data measuring the average consumer satisfaction index is unavailable in Fiscal Year 18 Quarter 4.

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.